Home › Funds › Citadel Advisors › DMAC

Citadel Advisors position in DMAC

DIAMEDICA THERAPEUTICS INC · Health Care

Latest position (Q2 2026)145.87K sh
Reported value held$1.03M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 105.35K $423.00K New
Q4 2021 115.80K $432.00K Add
Q1 2022 57.83K $145.00K Reduce
Q2 2022 18.01K $36.00K Reduce
Q3 2022 34.91K $43.00K Add
Q4 2022 40.92K $64.65K Add
Q1 2023 43.43K $66.45K Add
Q2 2023 15.11K $65.28K Reduce
Q3 2023 16.57K $42.74K Add
Q4 2023 25.91K $73.60K Add
Q1 2024 31.32K $86.76K Add
Q2 2024 10.71K $31.60K Reduce
Q3 2024 20.23K $84.77K Add
Q4 2024 25.21K $136.91K Add
Q1 2025 55.50K $210.34K Add
Q3 2025 69.35K $476.45K New
Q4 2025 151.34K $1.20M Add
Q1 2026 174.12K $1.18M Add
Q2 2026 145.87K $1.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding DMAC

All DMAC fund holders →